Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 25;118(5):1173-1187.
doi: 10.1093/cvr/cvab161.

Senescence mechanisms and targets in the heart

Maggie S Chen  1 , Richard T Lee  1   2 , Jessica C Garbern  1   3
Affiliations
Review

Senescence mechanisms and targets in the heart

Maggie S Chen et al. Cardiovasc Res. .

Abstract

Cellular senescence is a state of irreversible cell cycle arrest associated with ageing. Senescence of different cardiac cell types can direct the pathophysiology of cardiovascular diseases (CVDs) such as atherosclerosis, myocardial infarction, and cardiac fibrosis. While age-related telomere shortening represents a major cause of replicative senescence, the senescent state can also be induced by oxidative stress, metabolic dysfunction, and epigenetic regulation, among other stressors. It is critical that we understand the molecular pathways that lead to cellular senescence and the consequences of cellular senescence in order to develop new therapeutic approaches to treat CVD. In this review, we discuss molecular mechanisms of cellular senescence, explore how cellular senescence of different cardiac cell types (including cardiomyocytes, cardiac endothelial cells, cardiac fibroblasts, vascular smooth muscle cells, and valve interstitial cells) can lead to CVD, and highlight potential therapeutic approaches that target molecular mechanisms of cellular senescence to prevent or treat CVD.

Keywords: Ageing; Cardiovascular disease; Senescence; Senotherapy.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Markers of senescent cells. Senescent cells exhibit irreversible cell cycle arrest, elevation of p53, p21, and p16, elevation of DNA damage response markers p38 MAPK and γH2AX, hyperelongated mitochondria, elevated reactive oxygen species, increased senescence-associated β-galactosidase activity, senescence-associated heterochromatin foci (SAHF), and a senescence-associated secretory phenotype (SASP).
Figure 2
Figure 2
Molecular regulators of cellular senescence. Mechanisms that drive cellular senescence include the DNA damage response/telomere shortening, mTOR activation, metabolic dysfunction, circadian misalignment, SASP, tumour suppressor pathways, and epigenetic changes.
Figure 3
Figure 3
Tumour suppressor regulators of senescence. The p53/p21 and p16/Rb pathways play central roles in senescence via cell cycle arrest, ROS production, and activation of the DNA damage response.
Figure 4
Figure 4
Secretome of different cell types in the heart and examples of associated phenotypic changes. Senescent cardiac cells secrete different senescence-associated secretory phenotypes leading to paracrine signalling and exacerbation of the senescent phenotype. Several consequences of these secreted factors include fibrosis, myofibroblast activation, collagen synthesis, calcification, hypertrophy, and inflammation.
Figure 5
Figure 5
Senotherapeutic drugs. Senotherapies aim to eliminate senescent cells (senolytics), prevent acquisition of a senescent state (senostatics), or delay progression of senescence (SASP inhibitors).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Davalli P, Mitic T, Caporali A, Lauriola A, D'Arca D. ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases. Oxid Med Cell Longev 2016;2016:3565127. - PMC - PubMed
    1. Wang JC, Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 2012;111:245–259. - PubMed
    1. Das D, Holmes A, Murphy GA, Mishra K, Rosenkranz AC, Horowitz JD, Kennedy JA. TGF-beta1-Induced MAPK activation promotes collagen synthesis, nodule formation, redox stress and cellular senescence in porcine aortic valve interstitial cells. J Heart Valve Dis 2013;22:621–630. - PubMed
    1. Lee J, Termglinchan V, Diecke S, Itzhaki I, Lam CK, Garg P, Lau E, Greenhaw M, Seeger T, Wu H, Zhang JZ, Chen X, Gil IP, Ameen M, Sallam K, Rhee JW, Churko JM, Chaudhary R, Chour T, Wang PJ, Snyder MP, Chang HY, Karakikes I, Wu JC. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy. Nature 2019;572:335–340. - PMC - PubMed
    1. Chadda KR, Ajijola OA, Vaseghi M, Shivkumar K, Huang CL, Jeevaratnam K. Ageing, the autonomic nervous system and arrhythmia: from brain to heart. Ageing Res Rev 2018;48:40–50. - PubMed

Publication types